Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 2, 2013, Pages 250-258

  Bakdash, Ghaith ^a,b   Schneider, Laura P ^a   Van Capel, Toni M M ^a   Kapsenberg, Martien L ^a   Teunissen, Marcel B M ^a   De Jong, Esther C ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intradermal injection; Regulatory T cells; Skin dendritic cells; Tolerance; Vitamin D

Indexed keywords

CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; COLECALCIFEROL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; T6 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; EXPLANT; HUMAN; IMMUNOTHERAPY; LANGERHANS CELL; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN; CELL MOTION; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; PHYSIOLOGY; SECRETION (PROCESS);

ANTIGENS, CD14; CELL MOVEMENT; CHOLECALCIFEROL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INJECTIONS, INTRADERMAL; INTERFERON-GAMMA; LANGERHANS CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84874689449     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22918     Document Type: Article

References (51)

1. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11:7-13; PMID:20016504; http://dx.doi.org/10.1038/ni.1818.
2. Rudensky AY. Regulatory T cells and Foxp3. Immunol Rev 2011; 241:260-8; PMID:21488902; http://dx.doi.org/10.1111/j.1600-065X.2011.01018.x.
3. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685-98; PMID:19172691; http://dx.doi.org/10.1038/nri2378.
4. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81; PMID:17634462; http://dx.doi.org/10.1056/NEJMra070553.
5. Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991; 87:1103-7; PMID:1705564; http://dx.doi.org/10.1172/JCI115072.
6. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998 (Pubitemid 28087178)
7. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000
8. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994; 37:552-8; PMID:7926338; http://dx.doi.org/10.1007/BF00403372. (Pubitemid 24162425)
9. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol 2008
10. Sigmon JR, Yentzer BA, Feldman SR. Calcitriol ointment: a review of a topical vitamin D analog for psoriasis. J Dermatolog Treat 2009; 20:208-12; PMID:19444692; http://dx.doi.org/10.1080/09546630902936810.
11. Bikle DD. Vitamin D and the skin: Physiology and pathophysiology. Rev Endocr Metab Disord 2012; 13:3-19; PMID:21845365; http://dx.doi.org/10.1007/ s11154-011-9194-0.
12. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984; 74:1451-5; PMID:6332829; http://dx.doi.org/10.1172/JCI111557. (Pubitemid 15200239)
13. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986; 98:311-22; PMID:3489547; http://dx.doi.org/10.1016/0008-8749(86) 90291-1. (Pubitemid 16112035)
14. Reichel H, Koeffler HP, Tobler A, Norman AW. 1 alpha,25-Dihydroxyvitamin D3 inhibits gammainterferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A 1987; 84:3385-9; PMID:3033646; http://dx.doi.org/10.1073/pnas.84.10.3385. (Pubitemid 17085408)
15. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-And Th2-inducing cytokines. J Exp Med 2002; 195:603-16; PMID:11877483; http://dx.doi.org/10.1084/jem.20011629. (Pubitemid 34461505)
16. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183:5458-67; PMID:19843932; http://dx.doi.org/10.4049/jimmunol.0803217.
17. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, et al. Vitamin D3 affects differentiation, maturation, and function of human monocytederived dendritic cells. J Immunol 2000 (Pubitemid 30238038)
18. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 2001; 98:6800-5; PMID:11371626; http://dx.doi.org/10.1073/pnas.121172198. (Pubitemid 32538297)
19. Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005; 106:3490-7; PMID:16030186; http://dx.doi.org/10.1182/blood-2005-05- 2044. (Pubitemid 41609185)
20. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol 2009; 39:3147-59; PMID:19688742; http://dx.doi.org/10.1002/eji.200839103.
21. van der Aar AM, Sibiryak DS, Bakdash G, van Capel TM, van der Kleij HP, Opstelten DJ, et al. Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J Allergy Clin Immunol 2011; 127:1532-40, e7; PMID:21497886; http://dx.doi.org/10.1016/j.jaci.2011.01.068.
22. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8:285-93; PMID:17259988; http://dx.doi.org/10.1038/ni1433. (Pubitemid 46745378)
23. Gorman S, Kuritzky LA, Judge MA, Dixon KM, McGlade JP, Mason RS, et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J Immunol 2007
24. Enioutina EY, Bareyan D, Daynes RA. Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine 2007; 25:1236-49; PMID:17092617; http://dx.doi.org/10.1016/j.vaccine. 2006.10.008. (Pubitemid 46027341)
25. Daynes RA, Enioutina EY, Butler S, Mu HH, McGee ZA, Araneo B A. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun 1996 (Pubitemid 26102368)
26. Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol 2009; 182:6071-8; PMID:19414758; http://dx.doi.org/10. 4049/jimmunol.0804064.
27. Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993 (Pubitemid 23340400)
28. Valladeau J, Saeland S. Cutaneous dendritic cells. Semin Immunol 2005; 17:273-83; PMID:15953735; http://dx.doi.org/10.1016/j.smim.2005.05.009. (Pubitemid 40984021)
29. Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med 2012; 209:653-60; PMID:22430490; http://dx.doi.org/10.1084/jem.20111457.
30. Teunissen MB, Haniffa M, Collin MP. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Curr Top Microbiol Immunol 2012; 351:25-76; PMID:21833835; http://dx.doi.org/10.1007/82-2011-169.
31. de Gruijl TD, Luykx-de Bakker SA, Tillman BW, van den Eertwegh AJ, Buter J, Lougheed SM, et al. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol 2002 (Pubitemid 35217206)
32. Schneider LP, Schoonderwoerd AJ, Moutaftsi M, Howard RF, Reed SG, de Jong EC, et al. Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells. Vaccine 2012; 30:4216-24; PMID:22542815; http://dx.doi.org/10.1016/j. vaccine.2012.04.051.
33. Jenner E. An inquiry into the causes and effects of the variolae vaccinae: a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox(London: Edward Jenner, 1798).
34. Bonnotte B, Gough M, Phan V, Ahmed A, Chong H, Martin F, et al. Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells. Cancer Res 2003
35. Li N, Peng LH, Chen X, Nakagawa S, Gao JQ. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. Vaccine 2011; 29:6179-90; PMID:21740946; http://dx.doi.org/10.1016/j.vaccine.2011.06.086.
36. Chu CC, Ali N, Karagiannis P, Di Meglio P, Skowera A, Napolitano L, et al. Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 2012; 209:935-45; PMID:22547651; http://dx.doi.org/10.1084/jem.20112583.
37. van der Aar AM, Sylva-Steenland RM, Bos JD, Kapsenberg ML, de Jong EC, Teunissen MB. Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J Immunol 2007 (Pubitemid 46233394)
38. van der Aar AM, de Groot R, Sanchez-Hernandez M, Taanman EW, van Lier RA, Teunissen MB, et al. Cutting edge: virus selectively primes human langerhans cells for CD70 expression promoting CD8+ T cell responses. J Immunol 2011; 187:3488-92; PMID:21880979; http://dx.doi.org/10.4049/jimmunol. 1101105.
39. Klechevsky E, Liu M, Morita R, Banchereau R, Thompson-Snipes L, Palucka AK, et al. Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum Immunol 2009; 70:281-8; PMID:19236899; http://dx.doi.org/10.1016/j. humimm.2009.02.004.
40. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008; 29:497-510; PMID:18789730; http://dx.doi.org/10.1016/j.immuni. 2008.07.013.
41. Morelli AE, Rubin JP, Erdos G, Tkacheva OA, Mathers AR, Zahorchak AF, et al. CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. J Immunol 2005 (Pubitemid 41798351)
42. Angel CE, Lala A, Chen CJ, Edgar SG, Ostrovsky LL, Dunbar PR. CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts. Int Immunol 2007; 19:1271-9; PMID:17804688; http://dx.doi.org/10. 1093/intimm/dxm096. (Pubitemid 47604728)
43. Haniffa M, Ginhoux F, Wang XN, Bigley V, Abel M, Dimmick I, et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J Exp Med 2009; 206:371-85; PMID:19171766; http://dx.doi.org/10.1084/jem.20081633.
44. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-Alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001 (Pubitemid 32374175)
45. Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML, et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 2007; 127:331-41; PMID:17068485; http://dx.doi.org/10.1038/sj.jid.5700530. (Pubitemid 46106911)
46. Feldman D, Chen T, Hirst M, Colston K, Karasek M, Cone C. Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies. J Clin Endocrinol Metab 1980; 51:1463-5; PMID:6255007; http://dx.doi.org/10.1210/jcem-51-6-1463. (Pubitemid 11199647)
47. Lehmann B. The vitamin D3 pathway in human skin and its role for regulation of biological processes. Photochem Photobiol 2005; 81:1246-51; PMID:16162035; http://dx.doi.org/10.1562/2005-02-02-IR-430. (Pubitemid 43035833)
48. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A 2006; 103:11736-41; PMID:16880407; http://dx.doi.org/10.1073/pnas.0604575103. (Pubitemid 44182520)
49. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt RdeW, et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007; 25:193-219; PMID:17129180; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141718. (Pubitemid 46697907)
50. Teunissen MB, Koomen CW, Jansen J, de Waal Malefyt R, Schmitt E, Van den Wijngaard RM, et al. In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL-10 mRNA and protein. Clin Exp Immunol 1997; 107:213-23; PMID:9010278; http://dx.doi.org/10.1046/j.1365-2249.1997.d01-900.x. (Pubitemid 27019832)
51. de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, Wierenga EA, et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cellpromoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 2002 168:1704-9; PMID:11823500. (Pubitemid 34135767)